{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1047.582","meta":{"versionId":"5","lastUpdated":"2020-06-30T19:27:47.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"ASRS Quality Measure Development Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2020-06-30"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.582","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1047.582"}],"version":"20200319","name":"CorticosteroidsForInjection","title":"Corticosteroids for Injection","status":"active","experimental":false,"date":"2020-03-19T01:00:18-04:00","publisher":"ASRS Quality Measure Development Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: This value set includes concepts related to corticosteroids for injection.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication.),(Inclusion Criteria: Includes relevant concepts associated with corticosteroids for injection.),(Exclusion Criteria: No exclusions.)","compose":{"include":[{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.557"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.556"]}]},"expansion":{"identifier":"urn:uuid:109db041-c31b-4bbd-ae77-0ab6ec6ef074","timestamp":"2023-12-10T20:55:58-05:00","total":10,"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1792144","display":"1 ML triamcinolone acetonide 40 MG/ML Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1812079","display":"1 ML dexamethasone phosphate 10 MG/ML Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1812194","display":"1 ML dexamethasone phosphate 4 MG/ML Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1947131","display":"triamcinolone acetonide 32 MG Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"2045404","display":"0.005 ML dexamethasone 103.4 MG/ML Injection"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2023","code":"J1100","display":"Injection, dexamethasone sodium phosphate, 1 mg"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2023","code":"J3300","display":"Injection, triamcinolone acetonide, preservative free, 1 mg"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2023","code":"J3301","display":"Injection, triamcinolone acetonide, not otherwise specified, 10 mg"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2023","code":"J7312","display":"Injection, dexamethasone, intravitreal implant, 0.1 mg"},{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2023","code":"J7313","display":"Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg"}]}}